Colour enhancement - PsychonautWiki
Open main menu

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Experience:300µg LSD - Togetherness and the Silent Dusk
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
1P-LSD
Amanita muscaria
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
3C-E
4-AcO-DET
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
LSA
25I-NBOH
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Experience:250mg DXM - DXM Itch and Trip Report
4-HO-DPT
MDEA
2C-D
Phenethylamine (compound)
EPT
2C-T-2
Selective serotonin reuptake inhibitor
DPT
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience:4x 200ug tabs - You do not need to understand
PRO-LAD
Experience:2 tabs DOB - My DOB Nightmare
25D-NBOMe
5-MeO-DiPT
1P-ETH-LAD
Bromo-DragonFLY
DOM
Chameleon.jpgChameleon by Anonymous.
Experience:1000 Morning Glory seeds - Rediscovering the Self
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
MET
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
25I-NBOMe
Aniracetam
2C-T-7
4-AcO-MiPT
4-AcO-DMT
2C-E
MiPT
4-HO-MPT
5-MeO-MiPT
LSM-775
Experience:120mg - Garden of The Gods
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience:BK-2C-B - Various experiences
Enhancement of colour rose.jpgRose by Chelsea Morgan
2C-H
Phenylpiracetam
3-MeO-PCE
Experience:25mg Deschloroketamine - My first time orally dosing DCK
1B-LSD
Omberacetam
2C-I
DET
DOC
Methallylescaline
PARGY-LAD
6-APDB
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Pramiracetam
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
25C-NBOMe
Experience:4-HO-MiPT / A care free psychedelic getaway
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Coluracetam
Experience:800 seeds LSA - My First Trip Ever
Experience:25mg 3-MeO-PCP - Enhanced film experience
4-FA
Experience:3g mimosa / 3g syrian rue - Connecting with my body
5F-PB-22
25B-NBOH
5-MeO-DALT
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
ΑMT
6-APB
THJ-2201
Psilocybin mushrooms
4-HO-MiPT
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
5-MeO-DiBF
Proscaline
JWH-073
Pregabalin
Experience:3-MeO-PCP - Extreme psychosis
Paradise island by Xanny.jpgParadise island by Subsentience
2C-B-FLY
Mescaline
3-MMC
DiPT
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
MDA
AL-LAD
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
DOI
Experience:4.5g - The Grand Introduction to Beauty and Fear
Cannabis
GABAergic hallucinogens
4-AcO-MET
THJ-018
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
2C-C
Memantine
Ayahuasca
ETH-LAD
2C-P
4-HO-MET
2C-B
Oxiracetam
Βk-2C-B
MDMA
LSD
DOB
25C-NBOH
4-AcO-DiPT
Experience:1mg 25c-NBOMe - Experiment in my room
Efavirenz
2C-T-21
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Psilocin
Bufotenin
Experience:337mg DMT fumarate - A Day With DMT
Experience:40mg - Brothermind and the Forest's Hand
Tree.jpgJapanese Garden by Anonymous
MPT
Ibogaine
TMA-6
Allylescaline
Piracetam
25B-NBOMe
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
25N-NBOMe
MiPLA
DMT
5-Hydroxytryptophan
JWH-018
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
4-HO-DET
ALD-52
LSZ
Experience:4-AcO-DMT + 200mg Pill
Escaline
4-HO-DiPT
MDAI
4-HO-EPT
TMA-2

Contents

Psychoactive substances

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.